Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments

被引:2
|
作者
Shaji, Sreelakshmi [1 ]
Palanisamy, Rohini [2 ]
Swaminathan, Ramakrishnan [1 ]
机构
[1] Indian Inst Technol Madras, Dept Appl Mech, Biomed Engn Grp, Noninvas Imaging & Diagnost Lab, Chennai, India
[2] Indian Inst Informat Technol Design & Mfg, Chennai, India
关键词
Early Mild Cognitive Impairment; Corpus Callosum; Structural irregularity; Fourier analysis; Cerebrospinal fluid markers; ALZHEIMERS-DISEASE; CSF BIOMARKERS;
D O I
10.1016/j.neulet.2023.137329
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this study, irregularity measures from MR images of corpus callosal brain structures in healthy and Mild Cognitive Impairment (MCI) conditions are extracted and their association with Cerebrospinal Fluid (CSF) biomarkers are analyzed. For this, MR images of healthy controls, Early MCI (EMCI) and Late MCI (LMCI) subjects are considered from a public database. The considered images are preprocessed and corpus callosal structure is segmented. Structural irregularity measures are extracted from the segmented regions using Fourier analysis. Statistical tests are performed to identify the significant features which can characterize the MCI stages. Association of these measures with CSF amyloid beta and tau concentrations are further investigated. Results demonstrate that Fourier spectral analysis is able to characterize the non-periodic variations in the corpus callosal structures of healthy, EMCI and LMCI MR images. The callosal irregularity measures increase as the disease progresses from healthy to LMCI. Phosphorylated tau concentrations in CSF demonstrate a positive correlation with irregularity measures across the diagnostic groups. Significant association of callosal measures and amyloid beta levels are found to be absent in MCI stages. As corpus callosal structural irregularities due to early MCI condition and their association with CSF markers remain uncharacterized in the literature, this study seems to be clinically significant for the timely intervention of pre-symptomatic MCI stages.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia
    Sonnen, Joshua A.
    Montine, Kathleen S.
    Quinn, Joseph F.
    Breitner, John C. S.
    Montine, Thomas J.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 301 - 309
  • [2] Cerebrospinal fluid biomarkers in patients with mild cognitive impairment
    Nedkova Hristova, V.
    Escribano Paredes, J. B.
    Martinez Poles, J.
    Garcia Madrona, S.
    Garcia Ribas, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 241 - 241
  • [3] Cerebrospinal Fluid Biomarkers and CerebralMorphometry in Mild Cognitive Impairment
    Kaiser, Elmar
    Thomann, Anne K.
    Thomann, Philipp A.
    GEROPSYCH-THE JOURNAL OF GERONTOPSYCHOLOGY AND GERIATRIC PSYCHIATRY, 2011, 24 (02) : 65 - 70
  • [4] Association of cerebrospinal fluid biomarkers with neuropsychological and neuroimaging characteristics in patients with mild cognitive impairment
    Uspenskaya, O. V.
    Belushkina, N. N.
    Zaharov, V. V.
    Yakhno, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 409 - 409
  • [5] DIFFERENTIATION OF MILD COGNITIVE IMPAIRMENT CONDITION IN BRAIN MR IMAGES USING STRUCTURAL BIOMARKERS OF FORNIX
    Ali, Ahsan
    Shaji, Sreelakshmi
    Ronickom, Jac Fredo Agastinose
    Swaminathan, Ramakrishnan
    Biomedical Sciences Instrumentation, 2024, 60 (01) : 78 - 87
  • [6] Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
    Bayer-Carter, Jennifer L.
    Green, Pattie S.
    Montine, Thomas J.
    VanFossen, Brian
    Baker, Laura D.
    Watson, Stennis
    Bonner, Laura M.
    Callaghan, Maureen
    Leverenz, James B.
    Walter, Brooke K.
    Tsai, Elaine
    Plymate, Stephen R.
    Postupna, Nadia
    Wilkinson, Charles W.
    Zhang, Jing
    Lampe, Johanna
    Kahn, Steven E.
    Craft, Suzanne
    ARCHIVES OF NEUROLOGY, 2011, 68 (06) : 743 - 752
  • [7] Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment
    Ahmad, Shahzad
    Yang, Wei
    Orellana, Adelina
    Froelich, Lutz
    de Rojas, Itziar
    Cano, Amanda
    Boada, Merce
    Hernandez, Isabel
    Hausner, Lucrezia
    Harms, Amy C.
    Bakker, Margot H. M.
    Cabrera-Socorro, Alfredo
    Amin, Najaf
    Ramirez, Alfredo
    Ruiz, Agustin
    Van Duijn, Cornelia M.
    Hankemeier, Thomas
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [8] Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild Cognitive Impairment
    Mounsey, Anne L.
    Zeitler, Matthew R.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (11) : 714 - 715
  • [9] Longitudinal Cerebrospinal Fluid Biomarkers over Four Years in Mild Cognitive Impairment
    Mattsson, Niklas
    Portelius, Erik
    Rolstad, Sindre
    Gustavsson, Mikael
    Andreasson, Ulf
    Stridsberg, Mats
    Wallin, Anders
    Blennow, Kaj
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (04) : 767 - 778
  • [10] PLASMA HOMOCYSTEINE AND CEREBROSPINAL FLUID NEURODEGENERATION BIOMARKERS IN MILD COGNITIVE IMPAIRMENT AND DEMENTIA
    Alexopoulos, Panagiotis
    Guenther, Florian
    Popp, Julius
    Jessen, Frank
    Peters, Oliver
    Wolf, Stefanie
    Kneib, Thomas
    Kurz, Alexander
    Richter-Schmidinger, Tanja
    Lewczuk, Piotr
    Bleich, Stefan
    Wiltfang, Jens
    Kornhuber, Johannes
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (04) : 737 - 739